CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
Public ClinicalTrials.gov record NCT04734873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3, Randomized, Placebo Controlled, Double-blind, Multicenter, Stratified Study of CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
Study identification
- NCT ID
- NCT04734873
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Corvus Pharmaceuticals, Inc.
- Industry
- Enrollment
- 46 participants
Conditions and interventions
Conditions
Interventions
- CPI-006 2 mg/kg + SOC Drug
- CPI-006 1 mg/kg + SOC Drug
- Placebo + SOC Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2021
- Primary completion
- Aug 17, 2021
- Completion
- Aug 17, 2021
- Last update posted
- Sep 20, 2022
2021
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sharp Chula Vista Medical Center | Chula Vista | California | 91911 | — |
| El Centro Regional Medical Center | El Centro | California | 92243 | — |
| Sharp Grossmont Hospital | La Mesa | California | 91942 | — |
| Torrance Memorial Medical Center | Torrance | California | 90505 | — |
| Mayo Clinic - Jacksonville | Jacksonville | Florida | 32224 | — |
| Cambridge Medical Trials | Alexandria | Louisiana | 71301 | — |
| MedPharmics | Metairie | Louisiana | 70006 | — |
| Holy Cross Hospital | Silver Spring | Maryland | 20910 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794 | — |
| Cape Fear Valley Medical Center | Fayetteville | North Carolina | 28304 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04734873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04734873 live on ClinicalTrials.gov.